Measuring the economic costs of antimicrobial resistance in hospital settings

Summary of the centers for disease control and prevention-emory workshop

David Howard, Ralph Cordell, John E. McGowan, Randall Packard, R. Douglas Scott, Steven L. Solomon

Research output: Contribution to journalArticle

Abstract

Health systems administrators and clinicians need refined calculations of the attributable cost of infections due to drug-resistant microorganisms to develop and assess cost-effective prevention strategies that deal with these infections. To date, however, efforts to provide this information have yielded widely variable and often conflicting estimates. This lack of reproducibility is largely attributable to problems in study design and in the methods used to identify and measure costs. Addressing these methodological issues was the focus of a workshop that included participants from a broad range of backgrounds, including economics, epidemiology, health care management, health care outcomes research, and clinical care. This workshop summary presents the advantages and disadvantages of various research designs as well as particular methodological issues related to the measurement of the economic cost of resistance in health care settings. Suggestions are made for needed common definitions and approaches, study areas for future research are considered, and priority investigations are identified.

Original languageEnglish (US)
Pages (from-to)1573-1578
Number of pages6
JournalClinical Infectious Diseases
Volume33
Issue number9
DOIs
StatePublished - Nov 1 2001
Externally publishedYes

Fingerprint

Centers for Disease Control and Prevention (U.S.)
Economics
Education
Costs and Cost Analysis
Delivery of Health Care
Health Services Research
Infection
Administrative Personnel
Epidemiology
Research Design
Outcome Assessment (Health Care)
Health
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology

Cite this

Measuring the economic costs of antimicrobial resistance in hospital settings : Summary of the centers for disease control and prevention-emory workshop. / Howard, David; Cordell, Ralph; McGowan, John E.; Packard, Randall; Scott, R. Douglas; Solomon, Steven L.

In: Clinical Infectious Diseases, Vol. 33, No. 9, 01.11.2001, p. 1573-1578.

Research output: Contribution to journalArticle

Howard, David ; Cordell, Ralph ; McGowan, John E. ; Packard, Randall ; Scott, R. Douglas ; Solomon, Steven L. / Measuring the economic costs of antimicrobial resistance in hospital settings : Summary of the centers for disease control and prevention-emory workshop. In: Clinical Infectious Diseases. 2001 ; Vol. 33, No. 9. pp. 1573-1578.
@article{dc0cb57017eb4fd3b55611316554aa64,
title = "Measuring the economic costs of antimicrobial resistance in hospital settings: Summary of the centers for disease control and prevention-emory workshop",
abstract = "Health systems administrators and clinicians need refined calculations of the attributable cost of infections due to drug-resistant microorganisms to develop and assess cost-effective prevention strategies that deal with these infections. To date, however, efforts to provide this information have yielded widely variable and often conflicting estimates. This lack of reproducibility is largely attributable to problems in study design and in the methods used to identify and measure costs. Addressing these methodological issues was the focus of a workshop that included participants from a broad range of backgrounds, including economics, epidemiology, health care management, health care outcomes research, and clinical care. This workshop summary presents the advantages and disadvantages of various research designs as well as particular methodological issues related to the measurement of the economic cost of resistance in health care settings. Suggestions are made for needed common definitions and approaches, study areas for future research are considered, and priority investigations are identified.",
author = "David Howard and Ralph Cordell and McGowan, {John E.} and Randall Packard and Scott, {R. Douglas} and Solomon, {Steven L.}",
year = "2001",
month = "11",
day = "1",
doi = "10.1086/323758",
language = "English (US)",
volume = "33",
pages = "1573--1578",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Measuring the economic costs of antimicrobial resistance in hospital settings

T2 - Summary of the centers for disease control and prevention-emory workshop

AU - Howard, David

AU - Cordell, Ralph

AU - McGowan, John E.

AU - Packard, Randall

AU - Scott, R. Douglas

AU - Solomon, Steven L.

PY - 2001/11/1

Y1 - 2001/11/1

N2 - Health systems administrators and clinicians need refined calculations of the attributable cost of infections due to drug-resistant microorganisms to develop and assess cost-effective prevention strategies that deal with these infections. To date, however, efforts to provide this information have yielded widely variable and often conflicting estimates. This lack of reproducibility is largely attributable to problems in study design and in the methods used to identify and measure costs. Addressing these methodological issues was the focus of a workshop that included participants from a broad range of backgrounds, including economics, epidemiology, health care management, health care outcomes research, and clinical care. This workshop summary presents the advantages and disadvantages of various research designs as well as particular methodological issues related to the measurement of the economic cost of resistance in health care settings. Suggestions are made for needed common definitions and approaches, study areas for future research are considered, and priority investigations are identified.

AB - Health systems administrators and clinicians need refined calculations of the attributable cost of infections due to drug-resistant microorganisms to develop and assess cost-effective prevention strategies that deal with these infections. To date, however, efforts to provide this information have yielded widely variable and often conflicting estimates. This lack of reproducibility is largely attributable to problems in study design and in the methods used to identify and measure costs. Addressing these methodological issues was the focus of a workshop that included participants from a broad range of backgrounds, including economics, epidemiology, health care management, health care outcomes research, and clinical care. This workshop summary presents the advantages and disadvantages of various research designs as well as particular methodological issues related to the measurement of the economic cost of resistance in health care settings. Suggestions are made for needed common definitions and approaches, study areas for future research are considered, and priority investigations are identified.

UR - http://www.scopus.com/inward/record.url?scp=0035503204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035503204&partnerID=8YFLogxK

U2 - 10.1086/323758

DO - 10.1086/323758

M3 - Article

VL - 33

SP - 1573

EP - 1578

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 9

ER -